Sensona, Inc.
Michael Buhle is an accomplished business leader in the healthcare and diagnostics sectors, currently serving as Chief Commercial Officer and Board Member at Biovision Diagnostics, where a focus on innovative diagnostic platforms is aimed at enhancing patient health. Buhle's extensive experience includes pivotal roles such as Vice President of Sales for the Americas at Congenica, Senior Director of National Accounts at Danaher Corporation, and National Sales Director at Access Genetics. With a strong background in business development, Buhle has contributed to the launch of key molecular tests and has successfully built strategic partnerships across various healthcare sectors. Buhle holds a Bachelor of Arts in Business Administration from Clarke University.
This person is not in the org chart
This person is not in any teams
Sensona, Inc.
Sensona's technology delivers portable, 8-minute diagnostic tests using a novel approach based on the exclusive, internal heating system activated by Infra-Red-light sensitive nanoparticles. The unique nanoparticles were invented, synthesized, and purified by Sensona's R&D team. Our technology was recently granted the U.S. patent and several international patents, which provide us exclusive rights to manufacture and use the nanoparticles for the PCR, RT-PCR, qPCR, and other Nucleic Acid Amplification methods. Our portable, ultrafast, compact, and highly affordable system is the ultimate solution for detecting and rapidly diagnosing contagious outbreaks and provides a powerful tool to slow down the antibiotic-resistance threat. The future is here, and our first challenge is to give a serious fight against SARS-CoV-2. COVID-19 portable, rapid diagnostic tests at schools, airports, ambulances, army bases, shopping centers, and many other possibilities are not a dream anymore. The future is here! It's not magic; it's science!